Literature DB >> 8574836

Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens.

M P Daftarian1, F Diaz-Mitoma, W D Creery, W Cameron, A Kumar.   

Abstract

The loss of immune function following infection with human immunodeficiency virus (HIV) may result from altered production of immunoregulatory cytokines such as interleukin-10 (IL-10) and IL-12. In this study, we analyzed IL-10 and IL-12 production by mitogen-stimulated peripheral blood mononuclear cells (PBMC) from HIV+ individuals and correlated their levels with proliferative responses to the recall antigens HIV p25 and influenza virus. We report two distinct groups of HIV+ patients. One group produced small amounts of IL-10, had PBMC that proliferated in response to recall antigens, and demonstrated enhanced recall antigen-induced proliferation upon addition of anti-IL-10 antibodies and/or IL-12. Conversely, the second group produced high levels of IL-10, had PBMC that failed to proliferate to recall antigens, and did not demonstrate enhanced proliferation upon addition of anti-IL-10 antibodies and/or IL-12. Mitogen-stimulated PBMC from both groups produced significantly lower levels of IL-12 than did those from HIV- controls. Analysis of the source of the IL-10-producing cell subset in PBMC demonstrated that in HIV+ individuals, IL-10 is produced by monocytes, while in HIV- controls, it is produced by both T cells and monocytes. Taken together, our results suggest that monocytes from HIV+ individuals secrete decreased amounts of IL-12, a Th1-type cytokine, which may lead to the development of Th2-type responses characterized by high IL-10 secretion and immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574836      PMCID: PMC170227          DOI: 10.1128/cdli.2.6.712-718.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  53 in total

1.  Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.

Authors:  D Benjamin; T J Knobloch; M A Dayton
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

Review 2.  Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples.

Authors:  J S Abrams; M G Roncarolo; H Yssel; U Andersson; G J Gleich; J E Silver
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

Review 3.  Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1992-10

4.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

Authors:  L Ding; E M Shevach
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

5.  Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages.

Authors:  F Kazazi; J M Mathijs; J Chang; P Malafiej; A Lopez; D Dowton; T C Sorrell; M A Vadas; A L Cunningham
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

6.  Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients.

Authors:  F Diaz-Mitoma; A Kumar; S Karimi; M Kryworuchko; M P Daftarian; W D Creery; L G Filion; W Cameron
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

8.  Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen.

Authors:  M C Kullberg; E J Pearce; S E Hieny; A Sher; J A Berzofsky
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

9.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.

Authors:  J S Silva; P J Morrissey; K H Grabstein; K M Mohler; D Anderson; S G Reed
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  10 in total

1.  IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy.

Authors:  E Stylianou; P Aukrust; D Kvale; F Müller; S S Frøland
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Nef protein of human immunodeficiency virus and lipopolysaccharide induce expression of CD14 on human monocytes through differential utilization of interleukin-10.

Authors:  David Creery; Jonathan B Angel; Susan Aucoin; William Weiss; William D Cameron; Francisco Diaz-Mitoma; Ashok Kumar
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.

Authors:  G Vanham; L Penne; J Devalck; L Kestens; R Colebunders; E Bosmans; K Thielemans; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 4.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

5.  HIV-1 Nef inhibits lipopolysaccharide-induced IL-12p40 expression by inhibiting JNK-activated NFkappaB in human monocytic cells.

Authors:  Wei Ma; Sasmita Mishra; Niranjala Gajanayaka; Jonathan B Angel; Ashok Kumar
Journal:  J Biol Chem       Date:  2008-11-19       Impact factor: 5.157

6.  Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness.

Authors:  A Kumar; J B Angel; M P Daftarian; K Parato; W D Cameron; L Filion; F Diaz-Mitoma
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

7.  Relationship between inflammatory mediator patterns and anemia in HIV-1 positive and exposed children with Plasmodium falciparum malaria.

Authors:  Gregory C Davenport; James B Hittner; Tom Were; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-05-08       Impact factor: 10.047

8.  Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.

Authors:  Samuel O Pine; James G Kublin; Scott M Hammer; Joleen Borgerding; Yunda Huang; Danilo R Casimiro; M Juliana McElrath
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

9.  HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses.

Authors:  Evelyn Ngwa Lumngwena; Simon Metenou; Lindi Masson; Claudia Cicala; James Arthos; Zenda Woodman
Journal:  Retrovirology       Date:  2020-07-02       Impact factor: 4.602

10.  Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.

Authors:  Prashant Malhotra; Patrick Haslett; Barbara Sherry; David H Shepp; Paul Barber; Jonathan Abshier; Upal Roy; Helena Schmidtmayerova
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.